Skip to main content

Table 2 Analysis of factors associated with carbapenem-non-susceptibility in invasive Acinetobacter spp. isolates

From: The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

 Univariable analysisMultivariable analysis
OR(95% CI)p-valueOR(95% CI)p-value
Year of sampling
 2013–20171.02(0.88–1.18)0.8441.03(0.94–1.13)0.571
European region
 Northern11
 Western2.37(0.98–5.74)0.0562.66(1.04–6.82)0.041
 Southern109(47.2–250)< 0.00183.76(33.79–207.66)< 0.001
 Eastern88.4(38.3–204)< 0.00175.87(31.23–184.32)< 0.001
Patient gender
 Female11
 Male1.54(1.36–1.73)< 0.0011.17(1.03–1.33)0.013
Patient age
 < 1 years0.36(0.16–0.82)0.0140.24(0.10–0.59)0.002
 1–19 years0.20(0.12–0.32)< 0.0010.28(0.16–0.49)< 0.001
 20–39 years11
 40–59 years1.36(1.01–1.84)0.0441.25(0.88–1.77)0.217
 60–79 years1.20(0.91–1.58)0.1951.21(0.92–1.56)0.178
 80+ years0.78(0.58–1.07)0.1231.16(0.85–1.59)0.352
Specimen (sampling site)
 Blood11
 CSF1.42(1.00–2.01)0.0520.78(0.45–1.35)0.373
Hospital unit type
 Internal medicine11
 Intensive care6.62(5.26–8.33)< 0.0013.79(2.94–4.88)< 0.001
 Oncology0.49(0.32–0.74)< 0.0010.61(0.43–0.87)0.006
 Surgery1.47(1.16–1.88)0.0021.17(0.85–1.60)0.341
 Other0.64(0.47–0.85)0.0030.81(0.62–1.06)0.13
Season
 Warm months0.83(0.73–0.94)0.0030.86(0.73–1.02)0.087
 Cold months11
  1. Abbreviations: 95% CI 95% confidence interval, CSF Cerebrospinal fluid, OR Odds ratio